ArticleMolecules (Basel, Switzerland)2026
When Does Machine Learning Add Value over Theory? Predicting API Solubility in Binary Mixtures with COSMO-RS and DOOIT2 Across Diverse and Homogeneous Systems.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Predicting the solubility of active pharmaceutical ingredients (APIs) in binary aqueous-organic mixtures is critical for formulation design, yet remains challenging. Physics-based models such as COSMO-RS provide a solid theoretical foundation but often struggle with non-ideal mixing behavior in complex systems. This study asks a practical question: when does machine learning actually add value beyond established theory? We compared COSMO-RS with DOOIT2 (Dual-Objective Optimization with Iterative Feature Pruning), a hybrid COSMO-RS/machine-learning correction workflow, across two complementary datasets: 85 structurally diverse APIs and related formulation-relevant compounds (10,140 data points) and 37 acid-centered solutes (6030 data points). The datasets also incorporate newly measured solubilities of lidocaine, benzocaine, and vanillic acid in aqueous 4-formylmorpholine mixtures. DOOIT2 employs rigorous API-out Structured Group K-Fold validation with fold-specific ensemble models to ensure realistic assessment of generalization to unseen compounds. The obtained results are dataset-dependent. For the homogeneous acid series, COSMO-RS already delivers strong predictive performance (
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.